Twist Bioscience (TWST) News Today $28.89 +0.56 (+1.98%) Closing price 04:00 PM EasternExtended Trading$28.48 -0.41 (-1.42%) As of 07:32 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock TWST Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Twist Bioscience Co. (NASDAQ:TWST) CAO Robert F. Werner Sells 839 SharesMay 29 at 6:47 AM | insidertrades.comTwist Bioscience Co. (NASDAQ:TWST) Stake Raised by Nuveen Asset Management LLCNuveen Asset Management LLC increased its holdings in Twist Bioscience Co. (NASDAQ:TWST - Free Report) by 43.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 292,645 shares of the company's sMay 28 at 3:43 AM | marketbeat.comTwist Bioscience Co. (NASDAQ:TWST) Shares Sold by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLCUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC cut its stake in Twist Bioscience Co. (NASDAQ:TWST - Free Report) by 3.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 85May 27 at 4:40 AM | marketbeat.comTwist Bioscience Co. (NASDAQ:TWST) Stock Holdings Lessened by Voloridge Investment Management LLCVoloridge Investment Management LLC lowered its stake in Twist Bioscience Co. (NASDAQ:TWST - Free Report) by 55.3% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 139,991 shares of the company's stock after selling 172,977 sharesMay 27 at 4:39 AM | marketbeat.comTwist Bioscience Co. (NASDAQ:TWST) Shares Sold by Bank of America Corp DEBank of America Corp DE decreased its position in shares of Twist Bioscience Co. (NASDAQ:TWST - Free Report) by 71.0% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 184,464 shares of the company's stock after selling 451,268 shares duringMay 26 at 3:21 AM | marketbeat.comDennis Cho Sells 531 Shares of Twist Bioscience Co. (NASDAQ:TWST) StockTwist Bioscience Co. (NASDAQ:TWST - Get Free Report) insider Dennis Cho sold 531 shares of the firm's stock in a transaction dated Wednesday, May 21st. The stock was sold at an average price of $29.75, for a total transaction of $15,797.25. Following the completion of the sale, the insider now owns 105,318 shares of the company's stock, valued at $3,133,210.50. This trade represents a 0.50% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.May 25, 2025 | marketbeat.comPaula Green Sells 632 Shares of Twist Bioscience Co. (NASDAQ:TWST) StockTwist Bioscience Co. (NASDAQ:TWST - Get Free Report) SVP Paula Green sold 632 shares of the stock in a transaction that occurred on Wednesday, May 21st. The stock was sold at an average price of $29.75, for a total transaction of $18,802.00. Following the sale, the senior vice president now directly owns 128,748 shares of the company's stock, valued at approximately $3,830,253. This trade represents a 0.49% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink.May 25, 2025 | marketbeat.comTwist Bioscience Co. (NASDAQ:TWST) CFO Sells $27,846.00 in StockTwist Bioscience Co. (NASDAQ:TWST - Get Free Report) CFO Adam Laponis sold 936 shares of the stock in a transaction that occurred on Wednesday, May 21st. The stock was sold at an average price of $29.75, for a total value of $27,846.00. Following the completion of the transaction, the chief financial officer now owns 106,018 shares in the company, valued at $3,154,035.50. This represents a 0.88% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.May 25, 2025 | marketbeat.comTwist Bioscience Co. (NASDAQ:TWST) COO Sells $55,840.75 in StockTwist Bioscience Co. (NASDAQ:TWST - Get Free Report) COO Patrick John Finn sold 1,877 shares of the business's stock in a transaction on Wednesday, May 21st. The stock was sold at an average price of $29.75, for a total value of $55,840.75. Following the completion of the transaction, the chief operating officer now directly owns 240,783 shares of the company's stock, valued at approximately $7,163,294.25. The trade was a 0.77% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website.May 25, 2025 | marketbeat.comEmily M. Leproust Sells 2,802 Shares of Twist Bioscience Co. (NASDAQ:TWST) StockTwist Bioscience Co. (NASDAQ:TWST - Get Free Report) CEO Emily M. Leproust sold 2,802 shares of Twist Bioscience stock in a transaction that occurred on Wednesday, May 21st. The shares were sold at an average price of $29.75, for a total transaction of $83,359.50. Following the completion of the transaction, the chief executive officer now directly owns 649,630 shares in the company, valued at approximately $19,326,492.50. This represents a 0.43% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.May 25, 2025 | marketbeat.comTwo Sigma Advisers LP Has $10.02 Million Stake in Twist Bioscience Co. (NASDAQ:TWST)Two Sigma Advisers LP decreased its position in shares of Twist Bioscience Co. (NASDAQ:TWST - Free Report) by 23.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 215,600 shares of the company's stock aMay 25, 2025 | marketbeat.comTwist Bioscience Co. (NASDAQ:TWST) Shares Sold by Two Sigma Investments LPTwo Sigma Investments LP lowered its holdings in Twist Bioscience Co. (NASDAQ:TWST - Free Report) by 17.2% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 347,532 shares of the company's stock after selling 72,056May 25, 2025 | marketbeat.comAmeriprise Financial Inc. Trims Stake in Twist Bioscience Co. (NASDAQ:TWST)Ameriprise Financial Inc. lowered its stake in shares of Twist Bioscience Co. (NASDAQ:TWST - Free Report) by 12.0% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 139,067 shares of the company's stock after selling 19May 25, 2025 | marketbeat.comTwist Bioscience Co. (NASDAQ:TWST) Insider Dennis Cho Sells 531 SharesMay 24, 2025 | insidertrades.comTwist Bioscience (NASDAQ:TWST) Reaches New 52-Week Low - Here's WhyTwist Bioscience (NASDAQ:TWST) Sets New 52-Week Low - Here's WhyMay 24, 2025 | marketbeat.comMan Group plc Has $4.74 Million Stock Holdings in Twist Bioscience Co. (NASDAQ:TWST)Man Group plc trimmed its position in Twist Bioscience Co. (NASDAQ:TWST - Free Report) by 21.3% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 102,021 shares of the company's stock after selling 27,588 shares duriMay 24, 2025 | marketbeat.comWestwood Holdings Group Inc. Takes $657,000 Position in Twist Bioscience Co. (NASDAQ:TWST)Westwood Holdings Group Inc. purchased a new stake in shares of Twist Bioscience Co. (NASDAQ:TWST - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 14,138 shares of the companyMay 23, 2025 | marketbeat.comRafferty Asset Management LLC Lowers Stock Holdings in Twist Bioscience Co. (NASDAQ:TWST)Rafferty Asset Management LLC trimmed its stake in Twist Bioscience Co. (NASDAQ:TWST - Free Report) by 32.9% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 93,319 shares of the company's stock after selling 45May 21, 2025 | marketbeat.comGotham Asset Management LLC Sells 10,813 Shares of Twist Bioscience Co. (NASDAQ:TWST)Gotham Asset Management LLC trimmed its holdings in shares of Twist Bioscience Co. (NASDAQ:TWST - Free Report) by 39.0% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 16,925 shares of the company's stock after sMay 21, 2025 | marketbeat.comD. E. Shaw & Co. Inc. Increases Position in Twist Bioscience Co. (NASDAQ:TWST)D. E. Shaw & Co. Inc. increased its position in Twist Bioscience Co. (NASDAQ:TWST - Free Report) by 1,085.9% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 107,268 shares of the company's stock after acquiring an addiMay 20, 2025 | marketbeat.comDeutsche Bank AG Purchases 12,940 Shares of Twist Bioscience Co. (NASDAQ:TWST)Deutsche Bank AG grew its position in Twist Bioscience Co. (NASDAQ:TWST - Free Report) by 8.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 159,752 shares of the company's stock after purchasing anMay 20, 2025 | marketbeat.comTwist Bioscience Co. (NASDAQ:TWST) Shares Bought by BNP Paribas Financial MarketsBNP Paribas Financial Markets raised its stake in Twist Bioscience Co. (NASDAQ:TWST - Free Report) by 138.0% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 90,527 shares of the company's stock aftMay 17, 2025 | marketbeat.comMPM Bioimpact LLC Cuts Stake in Twist Bioscience Co. (NASDAQ:TWST)MPM Bioimpact LLC lowered its position in shares of Twist Bioscience Co. (NASDAQ:TWST - Free Report) by 9.3% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 267,497 shares of the company's stock after sellingMay 16, 2025 | marketbeat.comTwist Bioscience Co. (NASDAQ:TWST) Receives Average Rating of "Moderate Buy" from AnalystsShares of Twist Bioscience Co. (NASDAQ:TWST - Get Free Report) have earned a consensus rating of "Moderate Buy" from the ten ratings firms that are currently covering the stock, Marketbeat.com reports. One research analyst has rated the stock with a sell rating, one has given a hold rating and eiMay 15, 2025 | marketbeat.comTwist Bioscience Co. (NASDAQ:TWST) Stake Lessened by Iron Triangle Partners LPIron Triangle Partners LP lowered its stake in Twist Bioscience Co. (NASDAQ:TWST - Free Report) by 3.4% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 492,471 shares of the company's stock after selling 17,529 shares during the period. Twist Bioscience accountsMay 13, 2025 | marketbeat.comNorthern Trust Corp Acquires 51,926 Shares of Twist Bioscience Co. (NASDAQ:TWST)Northern Trust Corp increased its holdings in Twist Bioscience Co. (NASDAQ:TWST - Free Report) by 9.0% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 627,649 shares of the company's stock after buying aMay 13, 2025 | marketbeat.comAlgert Global LLC Sells 14,091 Shares of Twist Bioscience Co. (NASDAQ:TWST)Algert Global LLC trimmed its holdings in shares of Twist Bioscience Co. (NASDAQ:TWST - Free Report) by 32.3% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 29,501 shares of the company's stock after selling 14,09May 12, 2025 | marketbeat.comFarallon Capital Management LLC Sells 333,000 Shares of Twist Bioscience Co. (NASDAQ:TWST)Farallon Capital Management LLC reduced its holdings in shares of Twist Bioscience Co. (NASDAQ:TWST - Free Report) by 97.8% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 7,650 shares of the company's stock after selling 333,000 sMay 11, 2025 | marketbeat.comFY2025 Earnings Forecast for TWST Issued By Leerink PartnrsTwist Bioscience Co. (NASDAQ:TWST - Free Report) - Equities researchers at Leerink Partnrs reduced their FY2025 EPS estimates for shares of Twist Bioscience in a research report issued on Monday, May 5th. Leerink Partnrs analyst P. Souda now anticipates that the company will post earnings per shaMay 10, 2025 | marketbeat.comQ3 EPS Estimate for Twist Bioscience Increased by AnalystTwist Bioscience Co. (NASDAQ:TWST - Free Report) - Research analysts at William Blair upped their Q3 2025 earnings estimates for shares of Twist Bioscience in a research report issued on Monday, May 5th. William Blair analyst M. Larew now anticipates that the company will post earnings of ($0.52)May 10, 2025 | marketbeat.comTwist Bioscience Co. (NASDAQ:TWST) Shares Sold by AQR Capital Management LLCAQR Capital Management LLC cut its holdings in shares of Twist Bioscience Co. (NASDAQ:TWST - Free Report) by 14.3% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 160,774 shares of the company's stock after seMay 10, 2025 | marketbeat.comBosun Asset Management LLC Lowers Stock Position in Twist Bioscience Co. (NASDAQ:TWST)Bosun Asset Management LLC lessened its position in shares of Twist Bioscience Co. (NASDAQ:TWST - Free Report) by 49.3% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 8,091 shares of the company's stock after selling 7,876 shares during tMay 9, 2025 | marketbeat.comBayesian Capital Management LP Buys Shares of 10,811 Twist Bioscience Co. (NASDAQ:TWST)Bayesian Capital Management LP purchased a new stake in Twist Bioscience Co. (NASDAQ:TWST - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 10,811 shares of the company's stock, valued at aMay 9, 2025 | marketbeat.comTwist Bioscience Corporation (TWST): Among Nicholas J. Pritzker’s Stock Picks with Huge Upside PotentialMay 9, 2025 | msn.comTwist Bioscience's (TWST) "Buy" Rating Reaffirmed at GuggenheimGuggenheim reiterated a "buy" rating and set a $50.00 target price on shares of Twist Bioscience in a report on Tuesday.May 8, 2025 | marketbeat.comRobert W. Baird Issues Pessimistic Forecast for Twist Bioscience (NASDAQ:TWST) Stock PriceRobert W. Baird lowered their target price on shares of Twist Bioscience from $54.00 to $44.00 and set an "outperform" rating for the company in a research note on Tuesday.May 8, 2025 | marketbeat.comTwist Bioscience (NASDAQ:TWST) Price Target Cut to $33.00 by Analysts at JPMorgan Chase & Co.JPMorgan Chase & Co. lowered their price objective on shares of Twist Bioscience from $40.00 to $33.00 and set an "underweight" rating for the company in a research report on Tuesday.May 8, 2025 | marketbeat.comTwist Bioscience Co. (NASDAQ:TWST) Insider Dennis Cho Sells 689 SharesMay 8, 2025 | insidertrades.comTwist Bioscience and Ginkgo Bioworks Revise CollaborationMay 8, 2025 | businesswire.comTWIST BIOSCIENCE Earnings Results: $TWST Reports Quarterly EarningsMay 8, 2025 | nasdaq.comTWIST BIOSCIENCE Earnings Results: $TWST Reports Quarterly EarningsMay 8, 2025 | nasdaq.comTwist Bioscience (NASDAQ:TWST) Shares Gap Up - Here's WhyTwist Bioscience (NASDAQ:TWST) Shares Gap Up - Should You Buy?May 7, 2025 | marketbeat.comTwist Bioscience (NASDAQ:TWST) Releases Earnings Results, Misses Expectations By $0.10 EPSTwist Bioscience (NASDAQ:TWST - Get Free Report) posted its earnings results on Monday. The company reported ($0.66) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.56) by ($0.10). Twist Bioscience had a negative return on equity of 32.69% and a negative net margin of 59.76%.May 7, 2025 | marketbeat.comSchonfeld Strategic Advisors LLC Invests $2.68 Million in Twist Bioscience Co. (NASDAQ:TWST)Schonfeld Strategic Advisors LLC bought a new position in shares of Twist Bioscience Co. (NASDAQ:TWST - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 57,598 shares of thMay 7, 2025 | marketbeat.comTwist Bioscience: Expansion Efforts Continue To Face ChallengesMay 7, 2025 | seekingalpha.comCathie Wood’s ARK Investment buys 283.2K shares of Twist Bioscience todayMay 7, 2025 | msn.comTwist Bioscience Corporation (NASDAQ:TWST) Q2 2025 Earnings Call TranscriptMay 6, 2025 | msn.com5TWST : Where Twist Bioscience Stands With AnalystsMay 6, 2025 | benzinga.comDimensional Fund Advisors LP Has $40.85 Million Stock Holdings in Twist Bioscience Co. (NASDAQ:TWST)Dimensional Fund Advisors LP lowered its stake in Twist Bioscience Co. (NASDAQ:TWST - Free Report) by 8.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 878,998 shares of the company's stock after selling 83,229 shares during theMay 6, 2025 | marketbeat.comTwist Spins out DivisionMay 5, 2025 | baystreet.ca Get Twist Bioscience News Delivered to You Automatically Sign up to receive the latest news and ratings for TWST and its competitors with MarketBeat's FREE daily newsletter. Email Address TWST Media Mentions By Week TWST Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TWST News Sentiment▼0.830.87▲Average Medical News Sentiment TWST News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TWST Articles This Week▼257▲TWST Articles Average Week Get Twist Bioscience News Delivered to You Automatically Sign up to receive the latest news and ratings for TWST and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Blueprint Medicines News BridgeBio Pharma News Elanco Animal Health News Verona Pharma News Telix Pharmaceuticals Limited American Depositary Shares News Grifols News TG Therapeutics News Legend Biotech News Nuvalent News Axsome Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TWST) was last updated on 5/29/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredMan who predicted $100K Bitcoin sees a huge run coming for another coin …Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Twist Bioscience Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Twist Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.